This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Mead Johnson Nutrition Reports Third Quarter Earnings; Year To Date Constant Dollar Sales Up 7 Percent

On a non-GAAP basis, which excludes specified items, net earnings attributable to shareholders totaled $483.4 million, or $2.36 per diluted share, for the first three quarters of 2012, compared with $466.5 million, or $2.27 per diluted share, for the same period a year ago.

Nine-Month Segment Results

Sales in the Asia/Latin America segment were $2,036.4 million for the first nine months of 2012, up 12 percent from $1,824.6 million in 2011. Sales growth increased eight percent from price and five percent from volume, offset by a one percent from foreign exchange. The majority of the markets in the segment had double-digit constant-dollar sales growth from pricing and market growth, with market share gains in select markets. In China/Hong Kong, the rate of growth slowed compared to the prior year as a result of lower market share in China. Sales growth for the segment also benefited from the Argentine acquisition in March 2012. EBIT for the segment totaled $707.2 million, up 13 percent compared to $625.0 million in the third quarter a year ago. The EBIT increase was primarily related to sales growth and improved gross margin, partially offset by increased demand-generation investments.

The North America/Europe segment reported net sales of $883.8 million for the first nine months of 2012, compared to $941.1 million in 2011. Sales growth increased four percent from price, offset by a decline of nine percent from volume and a one percent reduction from foreign exchange. The volume decline was primarily in the United States and is attributed to lower market share, category consumption and births. Market share was lower in comparison to the prior year, when we benefited from a competitor’s recall, and due to the current-year impact of the unfounded media reports in December 2011 of alleged product contamination. EBIT totaled $163.9 million, compared with $251.2 million in the same period a year ago. The decrease was primarily due to a decline in sales and lower gross margin from higher commodity costs and unfavorable manufacturing variances from lower production volumes.

5 of 7

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 17,826.30 -279.47 -1.54%
S&P 500 2,081.18 -23.81 -1.13%
NASDAQ 4,931.8150 -75.9760 -1.52%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs